Premium
Flunarizine versus Pizotifen: A Double‐Blind Study in the Prophylaxis of Migraine
Author(s) -
Rascol A.,
Montastruc J.L.,
Rascol O.
Publication year - 1986
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.1986.hed2602083.x
Subject(s) - flunarizine , medicine , migraine , double blind , anesthesia , prophylactic treatment , calcium , placebo , alternative medicine , pathology
SYNOPSISThe calcium entry blocker flunarizine was compared with an antiserotonin agent, pizotifen, in the prophylaxis ofmigraine. Thirty‐five patients were treated under double‐blind conditions for four months. The number of migraineattacks gradually declined in both groups with an eventual mean reduction of 65% and 45% in the flunarizine andpizotifen groups respectively. The efficacy of the former drug developed somewhat faster but no statisticallysignificant differences between the groups were found. Weight gain was the main side effect in both groups. Otherside effects were rare.It is concluded that flunarizine is a useful alternative for the prophylactic treatment of migraine.